TOUS - ETF AI Analysis
Top Page
T. Rowe Price International Equity ETF (TOUS)
TOUS, the T. Rowe Price International Equity ETF, has a solid overall rating driven by high-quality global leaders like AstraZeneca, ASML, TotalEnergies, Sony, and Roche, which benefit from strong financial performance, positive earnings outlooks, and generally supportive technical trends. Some holdings such as Airbus and Recruit Holdings face issues like bearish momentum, overvaluation, or cash flow and supply chain challenges, which modestly weigh on the fund’s rating. The main risk factor is that several key positions show signs of rich valuations or technical caution, meaning returns could be more sensitive if market conditions weaken.
TOUS vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.69B
- Region
- Developed Markets
- Expense Ratio
- 0.50%
- Beta
- 0.71
- Issuer
- T. Rowe Price
- Inception Date
- Jun 14, 2023
- Dividend Yield
- 1.60%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
TOUS Summary
The T. Rowe Price International Equity ETF (TOUS) is a global stock fund that invests in companies outside the U.S., aiming to cover the “total market” across many countries and industries rather than tracking a single index. It holds well-known names like ASML and Sony, along with banks, healthcare firms, and consumer brands from Japan, the UK, Europe, and more. Someone might invest in TOUS to diversify beyond the U.S. and tap into growth from both developed and emerging international markets. A key risk is that foreign stocks can be volatile and may rise or fall sharply with global economic and currency changes.
How much will it cost me?
This ETF has an expense ratio of 0.50%, which means you’ll pay about $5 per year for every $1,000 invested. That’s higher than the average low-cost index ETF because TOUS is actively managed by T. Rowe Price, which typically charges more for research-driven stock selection.
What would affect this ETF?
This ETF focuses on developed markets outside the U.S., so it can benefit if international economies strengthen, global trade improves, and sectors like technology, financials, and industrials continue to grow, especially with strong companies such as ASML, AstraZeneca, and Sony among its top holdings. On the downside, weaker growth in Europe or Japan, rising interest rates that pressure financials and overall stock prices, currency swings versus the U.S. dollar, or new regulations affecting energy, health care, or large global companies could hurt future returns.
TOUS Top 10 Holdings
TOUS leans heavily into developed markets outside the U.S., with a clear tilt toward European and Japanese blue chips. ASML is a key engine for the fund, rising over the year despite some recent choppiness, while Roche and TotalEnergies add steady, upward momentum from health care and energy. On the flip side, AstraZeneca and Airbus have been lagging, acting like mild headwinds rather than full-on drags. Sony and Recruit Holdings show mixed but generally rising trends, underscoring the fund’s balanced, globally diversified positioning across sectors.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 NL:ASML | ASML Holding NV | 3.08% | $51.97M | EUR 490.32B | 43.37% | 76Outperform |
 AZN | AstraZeneca | ― | ― | ― | ― | 80Outperform |
 GB:ULVR | Unilever | 1.78% | $30.12M | GBP 106.21B | -4.59% | 72Outperform |
 GB:RR | Rolls-Royce Holdings | 1.57% | $26.60M | GBP 104.26B | 11.46% | 71Outperform |
 JP:6758 | Sony | 1.53% | $25.78M | JPY 24.54T | -4.78% | 73Outperform |
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 EADSF | Airbus Group SE | ― | ― | ― | ― | 68Neutral |
 FR:TTE | TotalEnergies SE | 1.45% | $24.51M | EUR 177.97B | 49.76% | 78Outperform |
 JP:6098 | Recruit Holdings Co | 1.37% | $23.10M | JPY 23.57T | 132.53% | 67Neutral |
 JP:8306 | Mitsubishi UFJ Financial Group | 1.34% | $22.70M | JPY 36.29T | 38.37% | 76Outperform |
TOUS Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TOUS, the sentiment is Negative. The current price of 37.42 is below the 20-day moving average (MA) of 38.00, below the 50-day MA of 38.54, and below the 200-day MA of 37.61, indicating a bearish trend. The MACD of -0.17 indicates Negative momentum. The RSI at 41.70 is Neutral, neither overbought nor oversold. The STOCH value of 40.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TOUS.
TOUS Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| TOUS | $37.42 | $40.00(6.89% Upside) | $1.69B | 0.50% | 65Neutral |
 DIHP | $33.37 | $41.34(23.88% Upside) | $6.60B | 0.27% | 67Neutral |
 DFIS | $34.91 | ― | $5.84B | 0.39% | 58Neutral |
 CGIE | $35.43 | $44.40(25.31% Upside) | $2.47B | 0.54% | 66Neutral |
 SEIE | $34.93 | $40.38(15.61% Upside) | $1.35B | 0.50% | 64Neutral |
 DFSI | $44.84 | $53.74(19.85% Upside) | $1.19B | 0.24% | 63Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TOUS | T. Rowe Price International Equity ETF | 37.42 | 4.00 | 11.95% | |
| DIHP | Dimensional International High Profitability ETF | 33.37 | 2.99 | 9.83% | |
| DFIS | Dimensional International Small Cap ETF | 34.91 | 4.14 | 13.45% | |
| CGIE | Capital Group International Equity ETF | 35.43 | 1.44 | 4.22% | |
| SEIE | SEI Select International Equity ETF | 34.93 | 4.37 | 14.29% | |
| DFSI | Dimensional International Sustainability Core 1 ETF | 44.84 | 4.32 | 10.67% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.